Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Glenmark Pharmaceuticals Ltd.
NSE: GLENMARK
|
BSE: 532296
|
ISIN: INE935A01035
|
Industry: Pharmaceuticals
Product Launch
|
Mid-range Performer
2004.4000
85.60
(
4.46
%)
NSE
Sep 03, 2025
15:31 PM
57.15% Gain from 52W Low
Volume:
1.4M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Glenmark Pharmaceuticals Ltd.
24 Aug 2023
Product Launch
2004.40
4.46%
GLENMARK PHARMACEUTICALS
Hold:
Glenmark Pharmaceuticals Ltd.
by
Geojit BNP Paribas
Target: 815
Target
Geojit BNP Paribas
Number of FII/FPI investors decreased from 404 to 396 in Jun 2025 qtr
More from Glenmark Pharmaceuticals Ltd.
Recommended
Market closes higher, Netweb Tech wins a Rs 1,734 cr IndiaAI Mission order for sovereign AI system
Trendlyne Marketwatch |
03 Sep 2025, 03:59PM
Five stocks to buy from analysts this week - September 2, 2025
The Baseline |
02 Sep 2025, 06:04PM
Earnings Call Transcript - Q4FY20 for Glenmark Pharmaceuticals
|
29 Jun 2020